Sugi Predict

Sugi Predict / Compounds / SCHEMBL19980484

SCHEMBL19980484

SCHEMBL19980484

Oc1nc(-c2cccc(-c3ccccc3)c2)nc(-c2cccc(-c3ccccc3)c2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 1/20 0.48
▸ GP6 Q9HCN6 1/20 0.47
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ ESR1 P03372 3/20 0.46
▸ NTSR1 P30989 1/20 0.46
▸ ESR2 Q92731 2/20 0.44
▸ HDAC4 P56524 1/20 0.44
▸ HDAC2 Q92769 1/20 0.44
▸ HDAC8 Q9BY41 1/20 0.44
▸ ALOX5 P09917 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ ACMSD Q8TDX5 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ PRSS1 P07477 1/20 0.42
▸ PRSS2 P07478 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20805610 0.98 KMO (0.47) KMOGP6MEN1KMT2AESR1
SCHEMBL9927384 0.89 GP6 (0.55) KMOGP6MEN1KMT2AL3MBTL1
SCHEMBL21709295 0.89 GP6 (0.55) KMOGP6MEN1KMT2AL3MBTL1
SCHEMBL30143470 0.89 GP6 (0.55) KMOGP6MEN1KMT2AL3MBTL1
SCHEMBL19762079 0.89 GP6 (0.55) KMOGP6MEN1KMT2AL3MBTL1
SCHEMBL17189945 0.89 GP6 (0.55) KMOGP6MEN1KMT2AL3MBTL1
SCHEMBL19762197 0.89 GP6 (0.55) KMOGP6MEN1KMT2AL3MBTL1
SCHEMBL19762080 0.89 GP6 (0.55) KMOGP6MEN1KMT2AL3MBTL1
SCHEMBL18134338 0.89 GP6 (0.55) KMOGP6MEN1KMT2AL3MBTL1
SCHEMBL29358203 0.89 GP6 (0.55) KMOGP6MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11466021-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2022-10-11 — — US disclosed
US-11447464-B2 Compounds with spirobifluorene-structures MERCK PATENT GMBH (DE) 2022-09-20 — — US disclosed
EP-3548486-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-10-27 — — EP disclosed
US-20190194164-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2019-06-27 — — US disclosed
WO-2018050584-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11447464-B2 Compounds with spirobifluorene-structures SLCO1B3, SLCO4C1, SLCO1B1 KMO 2164/4885GP6 1591/4885MEN1 1205/4885
US-20190194164-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES SLCO1B3, SLCO4C1, SLCO1B1 KMO 2164/4885GP6 1591/4885MEN1 1205/4885
US-11466021-B2 Materials for organic electroluminescent devices OR10J3, L1CAM, EPCAM KMO 2298/4885GP6 1721/4885MEN1 2049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.